Page 78 - 2021_06-Haematologica-web

S.G. Kellaway et al.
Dzierzak E, Speck NA. Runx1 is required
for the endothelial to haematopoietic cell transition but not thereafter. Nature. 2009;457(7231):887-891.
26. Eilken HM, Nishikawa S-I, Schroeder T. Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature. 2009;457(7231):896-900.
27. Glass C, Wuertzer C, Cui X, et al. Global identification of EVI1 target genes in acute myeloid leukemia. PLoS One. 2013;8(6): e67134.
28. Regha K, Assi SA, Tsoulaki O, Gilmour J, Lacaud G, Bonifer C. Developmental-stage- dependent transcriptional response to leukaemic oncogene expression. Nat Commun. 2015;6(1):7203.
29. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid line- age depends on the transcription factor Pax5. Nature. 1999;401(6753):556-562.
30. Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, Busslinger M. Gene repression by Pax5 in B cells is essen- tial for blood cell homeostasis and is reversed in plasma cells. Immunity. 2006;24(3):269-281.
31. Matsumoto A, Takeishi S, Kanie T, et al. p57 is required for quiescence and mainte- nance of adult hematopoietic stem cells. Cell Stem Cell. 2011;9(3):262-271.
32. Zhang Y, Stehling-Sun S, Lezon-Geyda K, et al. PR-domain–containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function. Blood. 2011;118(14):3853- 3861.
33. Durst KL, Hiebert SW. Role of RUNX fam- ily members in transcriptional repression and gene silencing. Oncogene. 2004;23(24): 4220-4224.
34. Petrovick MS, Hiebert SW, Friedman AD, Hetherington CJ, Tenen DG, Zhang DE. Multiple functional domains of AML1: PU.1 and C/EBP alpha synergize with dif- ferent regions of AML1. Mol Cell Biol. 1998;18(7):3915-3925.
35. Palmer S, Brouillet J-P, Kilbey A, et al. Evi-1 Transforming and repressor activities are mediated by CtBP co-repressor proteins. J Biol Chem. 2001;276(28):25834-25840.
36.Thambyrajah R, Mazan M, Patel R, et al. GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruit- ment of LSD1. Nat Cell Biol. 2016;18(1):21- 32.
37. Lancrin C, Mazan M, Stefanska M, et al. GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothe- lium during hematopoietic commitment. Blood. 2012;120(2):314-322.
38. Ayoub E, Wilson MP, McGrath KE, et al. EVI1 overexpression reprograms hematopoiesis
via upregulation of Spi1 transcription. Nat
Commun. 2018;9(1): 4239.
39. Laricchia-Robbio L, Premanand K, Rinaldi
40.
CR, Nucifora G. EVI1 impairs myelopoiesis by deregulation of PU.1 function. Cancer Res. 2009;69(4):1633-1642.
Huang G, Zhang P, Hirai H, et al. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat Genet. 2008;40(1):51-60.
41.Hu Z, Gu X, Baraoidan K, et al. RUNX1 regulates corepressor interactions of PU.1. Blood. 2011;117(24):6498-6508.
42.Staber Philipp B, Zhang P, Ye M, et al. Sustained PU.1 levels balance cell-cycle reg- ulators to prevent exhaustion of adult hematopoietic stem cells. Mol Cell. 2013;49(5):934-946.
43. Aikawa Y, Katsumoto T, Zhang P, et al. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. Nat Med. 2010;16(5):580-585.
44. Di Genua C, Norfo R, Rodriguez-Meira A, et al. Cell-intrinsic depletion of Aml1-ETO- expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation. Haematologica. 2019;104(11):2215-2224.
45. Bushweller JH. Targeting transcription fac- tors in cancer — from undruggable to reali- ty. Nat Rev Cancer. 2019;19(11):611-624.
1580
haematologica | 2021; 106(6)